HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Second Time Lucky? Sumatriptan One Of Three Switches On The Cards In Germany

Executive Summary

A second attempt at switching sumatriptan for migraines, as well as switch applications for non-steroidal anti-inflammatories ketoprofen and liquid ibuprofen, are all on the agenda at Germany's next Expert Committee for Prescription meeting in June. 

Advertisement

Related Content

France Warns Of Serious Complications Related To OTC Ibuprofen Use
Germany Approves Trilogy Of Switches
EMA’s Frias Defends EU Centralized Switch Procedure Despite Only Delivering Four Reclassifications In 10 Years
German Expert Panel Opposes OTC Ibuprofen/Phenylephrine Combo, Hydrocortisone 1%
An Expert’s Guide To Switching In Germany, Part 2: Improving The Reclassification Process
Switchers, apply here, says HPRA
Rowex launches OTC sumatriptan in Ireland
Bayer's Actron OTC ketoprofen set to launch "within weeks".

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS148822

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel